Autolus Therapeutics AUTL
NASDAQ AUTL
$1.85 -0.09 (-4.64%)
At close: Oct 1, 2026 · 4:00 PM EDT

Autolus Therapeutics (AUTL) Other Non-Current Liabilities (2021 - 2026)

Updated

Autolus Therapeutics (AUTL) recorded Other Non-Current Liabilities of $474,000 in Q2 2026, down 0.6% from $477,000 a year earlier.

Analysis

Autolus Therapeutics (AUTL) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

At the end of FY2025, Autolus Therapeutics reported Other Non-Current Liabilities of $477,000, up 12.0% from FY2024.

  • Annual Other Non-Current Liabilities has increased for three straight years, with a four-year compound annual growth rate of 38.9% (FY2021 to FY2025).
  • Across earlier years, Other Non-Current Liabilities came in at $426,000 in FY2024 (+19.3%), $357,000 in FY2023 (+207.8%), $116,000 in FY2022 (-9.4%) and $128,000 in FY2021.
  • Quarterly Other Non-Current Liabilities has ranged from $105,000 in Q3 2022 to $477,000 in Q4 2025 over the past five years.
  • On a year-over-year basis, Other Non-Current Liabilities rose in six of the last seven quarters, with growth averaging 15.9%.
  • Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 258.8% in Q1 2024, against a decline of 9.4% in Q4 2022 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Autolus Therapeutics 688.78 Mn -635.30 Mn 25.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 474,000.00
Dec 31, 2025 477,000.00
Sep 30, 2025 472,000.00
Jun 30, 2025 477,000.00
Mar 31, 2025 444,000.00
Dec 31, 2024 426,000.00
Sep 30, 2024 447,000.00
Jun 30, 2024 415,000.00
Mar 31, 2024 409,000.00
Dec 31, 2023 357,000.00
Sep 30, 2023 295,000.00
Jun 30, 2023 122,000.00
Mar 31, 2023 114,000.00
Dec 31, 2022 116,000.00
Sep 30, 2022 105,000.00
Jun 30, 2022 115,000.00
Mar 31, 2022 124,000.00
Dec 31, 2021 128,000.00
API Access

Autolus Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AUTL&period=max&api_key=YOUR_API_KEY